<DOC>
	<DOCNO>NCT00290095</DOCNO>
	<brief_summary>The purpose study determine Clinically important difference Response shift quality life patient Multiple Myeloma .</brief_summary>
	<brief_title>Quality Life Patients With Multiple Myeloma</brief_title>
	<detailed_description>Multiple myeloma plasma cell tumor annual incidence 6 pr . 100 000 . In absence curative treatment , aim therapy induce objective response prolongation survival also improve patient quality life . This project raise two problem make QoL-data hard interpret 1 . In clinical trial many patient include , statistically significant difference obtain . However , widespread agreement p-values indicate whether particular find clinical significance statistical significance necessarily equate meaningful difference change QoL . A crucial task clinician interpret trial-based QoL result determine observed change clinically important patient . 2 . When measure change QoL pretest-posttest design , response shift affect result . Patients advanced disease report surprisingly good QoL.Including response shift quality life research would allow good understanding change QoL patient report .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<criteria>Multiple Myeloma Age &gt; 18 year Informed consent Terminal illness life expectancy le 3 month Unable fill questionnaire norwegian</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Multiple Myeloma</keyword>
	<keyword>Quality Life</keyword>
	<keyword>Response Shift</keyword>
	<keyword>Clinically Important Difference</keyword>
</DOC>